Skip Navigation

Health Policy and Planning 2004 19(5):271-278; doi:10.1093/heapol/czh032
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smith, R.
Right arrow Articles by Drager, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R.
Right arrow Articles by Drager, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press, 2004

Communicable disease control: a ‘Global Public Good’ perspective

Richard Smith1, David Woodward2, Arnab Acharya3, Robert Beaglehole4 and Nick Drager2

1 Health Economics, Law and Ethics Group, School of Medicine, Health Policy & Practice, University of East Anglia, Norwich, UK
2 Strategy Unit, Director General’s Office, World Health Organization, Geneva, Switzerland
3 Institute of Development Studies, University of Sussex, Brighton, UK
4 Department of Health Service Provision, World Health Organization, Geneva, Switzerland

Correspondence: Richard Smith, Health Economics, Law and Ethics Group, School of Medicine, Health Policy & Practice, University of East Anglia, Norwich, NR4 7TJ, UK. Tel: +44 (0)1603 593617, fax: +44 (0)1603 593604, email: Richard.Smith{at}uea.ac.uk

Despite the increasing ‘globalization’ of health, the responsibility for it remains primarily national, generating a potential mismatch between global health problems and current institutions and mechanisms to deal with them. The ‘Global Public Good’ (GPG) concept has been suggested as a framework to address this mismatch in different areas of public policy. This paper considers the application of the GPG concept as an organizing principle for communicable disease control (CDC), considering in particular its potential to improve the health and welfare of the developing world.

The paper concludes that there are significant limitations to the GPG concept’s effectiveness as an organizing principle for global health priorities, with respect to CDC. More specifically, there are few areas of CDC which qualify as GPG, and even among those that can be considered GPGs, it is not necessarily appropriate to provide everything which can be considered a GPG. It is therefore suggested that it may be more useful to focus instead on the failure of ‘collective action’, where the GPG concept may then: (1) provide a rationale to raise funds additional to aid from developed countries’ domestic budgets; (2) promote investment by developed countries in the health systems of developing countries; (3) promote strategic partnerships between developed and developing countries to tackle major global communicable diseases; and (4) guide the political process of establishing, and mechanisms for providing and financing, global CDC programmes with GPG characteristics, and GPGs which have benefits for CDC.

In short, the GPG concept is not without limitations and weaknesses as an organizing principle, but does provide, at least in some areas, guidance in improving collective action at the international level for the improvement of global CDC.

Key Words: public goods, globalization, communicable disease control


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Epidemiol. Community HealthHome page
R. D Smith
Trade and public health: facing the challenges of globalisation.
J Epidemiol Community Health, August 1, 2006; 60(8): 650 - 651.
[Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
R. Laxminarayan, M. Over, and D. L. Smith
Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
Health Aff., March 1, 2006; 25(2): 325 - 336.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
N. Wilson
Infectious diseases in Iraq have international implications
BMJ, November 27, 2004; 329(7477): 1289 - 1289.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.